Niu S - Search Results

1

Comparative efficacy and safety of 8 GLP-1RAs in patients with type 2 diabetes: A network meta-analysis.

Xia L, Shen T, Dong W, Su F, Wang J, Wang Q, Niu S, Fang Y. Xia L, et al. Among authors: niu s. Diabetes Res Clin Pract. 2021 Jul;177:108904. doi: 10.1016/j.diabres.2021.108904. Epub 2021 Jun 6. Diabetes Res Clin Pract. 2021. PMID: 34102249 Review.

2

A randomized phase I clinical trial comparing the pharmacokinetic, safety, and immunogenicity of potential biosimilar recombinant human HER2 monoclonal antibody for injection and trastuzumab in healthy Chinese adults.

Wang J, Niu S, Dong W, Wei L, Ou L, Zhang T, Zhang L, Nie X, Wang Q, Shen T, Wang Q, Xia L, Liu G, Jin J, Zheng Q, Song H, Fang Y. Wang J, et al. Among authors: niu s. Expert Opin Investig Drugs. 2020 Jul;29(7):755-762. doi: 10.1080/13543784.2020.1770226. Epub 2020 Jun 27. Expert Opin Investig Drugs. 2020. PMID: 32594779 Clinical Trial.

3

A Systematic Review and Meta-Analysis: Safety and Efficacy of Mesenchymal Stem Cells Therapy for Heart Failure.

Shen T, Xia L, Dong W, Wang J, Su F, Niu S, Wang Q, Fang Y. Shen T, et al. Among authors: niu s. Curr Stem Cell Res Ther. 2021;16(3):354-365. doi: 10.2174/1574888X15999200820171432. Curr Stem Cell Res Ther. 2021. PMID: 32867655

4

A Randomized Study on the Bioequivalence of Desloratadine in Healthy Chinese Subjects and the Association of Different Metabolic Phenotypes With UGT2B10 and CYP2C8 Genotypes.

Niu S, Li Y, Dong W, Xia L, Shen T, Wang J, Wang Q, Zhang T, Zhang M, Liu G, Guo D, Fang Y. Niu S, et al. Curr Drug Metab. 2020;21(13):1031-1039. doi: 10.2174/1389200221999201027143903. Curr Drug Metab. 2020. PMID: 33109037 Clinical Trial.

5

Randomised, double-blind, multicentre, phase Ⅰ/Ⅱ dose escalation and expansion trial of GR1501 in patients with plaque psoriasis: study protocol.

Dong W, Nie X, Wang J, Xia L, Cai L, Wang Q, Wang W, Fu W, Wang Q, Shen T, Fan H, Niu S, Cui Y, Zheng Q, Zhang J, Fang Y. Dong W, et al. Among authors: niu s. BMJ Open. 2020 Nov 24;10(11):e039067. doi: 10.1136/bmjopen-2020-039067. BMJ Open. 2020. PMID: 33234634 Free PMC article.

6

Pharmacokinetic bioequivalence, safety, and immunogenicity of GB222, a bevacizumab biosimilar candidate, and bevacizumab in Chinese healthy males: a randomized clinical trial.

Dong W, Chen M, Niu S, Wang B, Xia L, Wang J, Shen T, Wang Q, Lv J, Liu G, Fan H, Xie Z, Xie F, An Y, Zheng Q, Rao H, Song H, Fang Y. Dong W, et al. Among authors: niu s. Expert Opin Biol Ther. 2022 Feb;22(2):253-262. doi: 10.1080/14712598.2021.1954157. Epub 2021 Jul 26. Expert Opin Biol Ther. 2022. PMID: 34236011 Clinical Trial.

7

A Randomized Controlled Dose-Escalation Study of LY06006, a Recombinant Humanized Monoclonal Antibody to RANKL, in Chinese Healthy Adults.

Niu S, Chen M, Yan D, Liu X, Guo S, Ou L, Fan H, Lv J, Wang Q, Dong W, Xia L, Wang S, Liu G, Gu Q, Guo D, Liu H, Rao H, Zheng Q, Nie X, Song H, Fang Y. Niu S, et al. Front Pharmacol. 2022 Jun 15;13:893166. doi: 10.3389/fphar.2022.893166. eCollection 2022. Front Pharmacol. 2022. PMID: 35784742 Free PMC article.

8

The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies.

Yan D, Fan H, Chen M, Xia L, Wang S, Dong W, Wang Q, Niu S, Rao H, Chen L, Nie X, Fang Y. Yan D, et al. Among authors: niu s. Front Pharmacol. 2022 Aug 24;13:950450. doi: 10.3389/fphar.2022.950450. eCollection 2022. Front Pharmacol. 2022. PMID: 36091777 Free PMC article.

9

Efficacy and safety of oncolytic virus combined with chemotherapy or immune checkpoint inhibitors in solid tumor patients: A meta-analysis.

Liu X, Zhang J, Feng K, Wang S, Chen L, Niu S, Lu Q, Fang Y. Liu X, et al. Among authors: niu s. Front Pharmacol. 2022 Nov 14;13:1023533. doi: 10.3389/fphar.2022.1023533. eCollection 2022. Front Pharmacol. 2022. PMID: 36452227 Free PMC article.

10

Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Gerilimzumab (GB224), a recombinant humanized interleukin-6 monoclonal antibody, in healthy Chinese adults: A randomized controlled dose-escalation study.

Yan D, Niu S, Hu D, Dong W, Sun Y, Wang Q, Wang S, Gu Q, Liu G, Wang J, Chen L, Lv J, Zheng Q, Song H, Fang Y. Yan D, et al. Among authors: niu s. Expert Opin Investig Drugs. 2023 Feb;32(2):161-170. doi: 10.1080/13543784.2023.2178894. Epub 2023 Feb 20. Expert Opin Investig Drugs. 2023. PMID: 36755413 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,358 results

Search Page

Filters